AbbVie Inc.
ABBVNYSETrackedESG Rated: 2/2 ProvidersMarket Data VerifiedHealth CareBiotechnologyMSCI: BBBSustainalytics: 25.0 · Medium
- Coverage
- Rated universe Carries an MSCI or Sustainalytics observation.
- ESG profile reviewed
- Last editorial update to this profile.
- Quote
- Last verified closeObservation time is shown beside the price.
- Methodology
- How we rateProvider ratings are shown separately, never blended.
Market overview
Up+USD 2.66 (+0.94%) Day change
The market is closed. This is the last verified closing quote, not an intraday price.
- Open
- USD 286.83
- Previous close
- USD 283.54
- Day high
- USD 290.23
- Day low
- USD 284.85
- Volume
- 8,755,117
- Market cap
- USD 505,891,782,656
View Chart Data
| Date and time | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| USD 233.54 | USD 238.15 | USD 230.36 | USD 232.91 | 7,618,400 | |
| USD 231.13 | USD 231.54 | USD 223.12 | USD 224.13 | 9,365,900 | |
| USD 217.26 | USD 219.82 | USD 215.88 | USD 219.26 | 5,816,400 | |
| USD 223.42 | USD 223.96 | USD 220.12 | USD 223.26 | 6,767,700 | |
| USD 229.71 | USD 232.55 | USD 226.48 | USD 226.92 | 5,410,900 | |
| USD 225.12 | USD 227.81 | USD 223.57 | USD 225.37 | 7,607,000 | |
| USD 211.42 | USD 213.49 | USD 209.12 | USD 209.40 | 5,654,000 | |
| USD 204.80 | USD 210.42 | USD 204.06 | USD 210.26 | 6,199,400 | |
| USD 198.00 | USD 201.42 | USD 196.23 | USD 197.38 | 7,467,600 | |
| USD 192.00 | USD 205.83 | USD 190.75 | USD 203.89 | 10,406,300 | |
| USD 209.50 | USD 213.51 | USD 208.35 | USD 210.77 | 5,006,500 | |
| USD 219.02 | USD 219.60 | USD 214.90 | USD 217.72 | 7,618,500 | |
| USD 226.00 | USD 226.50 | USD 220.00 | USD 221.59 | 5,261,900 | |
| USD 250.75 | USD 251.80 | USD 247.56 | USD 251.06 | 6,988,000 | |
| USD 257.00 | USD 260.96 | USD 254.29 | USD 254.49 | 6,872,400 | |
| USD 251.45 | USD 256.20 | USD 244.44 | USD 245.10 | 7,435,600 | |
| USD 253.93 | USD 259.18 | USD 252.41 | USD 258.92 | 5,010,200 | |
| USD 262.70 | USD 262.97 | USD 257.70 | USD 261.72 | 4,225,200 | |
| USD 263.29 | USD 266.34 | USD 262.44 | USD 263.96 | 8,176,600 | |
| USD 259.74 | USD 264.06 | USD 257.87 | USD 262.82 | 5,861,400 | |
| USD 284.23 | USD 287.93 | USD 282.59 | USD 282.68 | 4,171,300 | |
| USD 288.69 | USD 291.32 | USD 284.70 | USD 286.00 | 5,367,600 | |
| USD 296.58 | USD 297.25 | USD 293.56 | USD 295.03 | 3,261,200 | |
| USD 290.00 | USD 292.55 | USD 284.91 | USD 286.01 | 4,839,300 |
Company Profile & Business Model Overview
Sustainability Strengths & Catalysts (Pros)
- Life-changing treatments for autoimmune and other diseases
- 25% carbon emission reduction goal with renewable energy adoption
- Strong compliance programs critical for pharma industry
Material Risks & Governance Concerns (Cons)
- Aggressive Humira pricing and patent strategies drew major criticism
- Drug affordability remains key social responsibility challenge
Related ESG Peer Equities
Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.
ESG & Sustainability Rating Breakdown
MSCI and Sustainalytics ratings shown side by side, never blended into a single score.
Third-party ratings
MSCI ESG industry rating benchmark.
Medium
Data integrity and methodology
MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.
Financial & Valuation Fundamentals
Valuation metrics for this profile. Market cap is taken from the delayed market quote above.
Related ESG Financial Tools & Modeling
ESG Investment Growth Calculator
Project compound future portfolio values versus traditional index benchmarks.
Launch Tool →
Portfolio Carbon Footprint Calculator
Translate your investment capital into financed greenhouse gas emissions.
Launch Tool →
Green Mortgage Calculator
Calculate interest rate discounts on energy-efficient certified homes.
Launch Tool →
Featured Sustainable Investment Research & Guides
Top 12 Impact Investing Apps & Platforms (Reviewed)
Comprehensive review of the best ESG micro-investing and direct indexing apps.
Biblically Responsible Investing (BRI): Top Stocks & Funds
Faith-based screening criteria, ESG alignment, and values-based portfolio strategies.
Top Desalination & Clean Water Infrastructure Stocks
Invest in global clean water purification, reverse osmosis, and municipal utilities.
Best Certified B-Corp Banks & Sustainable Banking
How to align your everyday cash reserves with social and climate impact standards.
Frequently Asked Questions
Direct answers on sustainability scores, risk methodologies, and peer rankings.
What is AbbVie Inc. (ABBV)'s ESG rating and sustainability score?
AbbVie Inc. (ABBV) currently holds an MSCI ESG rating of BBB and a Sustainalytics ESG Risk Score of 25.0 (Medium risk). Ratings evaluate environmental emissions, labor standards, board independence, and regulatory compliance.
Is AbbVie Inc. considered an ESG leader or laggard in Health Care?
AbbVie Inc. is classified as an Average ESG performer by MSCI with a BBB rating, indicating performance in line with mainstream sector peers with opportunities for further disclosure and risk management.
What are the main ESG risks and controversies for AbbVie Inc.?
Key material risks for AbbVie Inc. include: Aggressive Humira pricing and patent strategies drew major criticism; Drug affordability remains key social responsibility challenge. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.
How does The Impact Investor evaluate ESG stock profiles?
The Impact Investor presents third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.